Miryan Mahsa, Darbandi Mitra, Moradi Mozhgan, Najafi Farid, Soleimani Davood, Pasdar Yahya
Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Nutritional Sciences Department, School of Nutrition Sciences and Food Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Front Nutr. 2023 Feb 22;10:1062008. doi: 10.3389/fnut.2023.1062008. eCollection 2023.
Despite evidence supporting the beneficial effects of the Mediterranean diet (MedDiet) on hepatic steatosis in subjects with non-alcoholic fatty liver disease (NAFLD), the relationship of the MedDiet with hepatic fibrosis is as yet unclear. The aim of the present study was to explore this association in Iranian adults with NAFLD.
This cross-sectional study included 3,325 subjects with NAFLD from the Ravansar Noncommunicable Disease (RaNCD) cohort. Dietary intake data were collected by a validated food frequency questionnaire (FFQ). The MedDiet score was computed based on a nine-point scale constructed by Trichopoulou et al. Fatty liver index (FLI) and fibrosis-4 (FIB-4) index were used to predict hepatic steatosis and fibrosis in the population. Multivariate regression models were applied to determine associations.
Subjects in the highest tertile of MedDiet score had a higher platelet and a lower weight, total cholesterol (TC), LDL-c, and FLI than those in the lowest tertile (-value < 0.05). Adherence to the MedDiet was associated with a 7.48 (95%CI: 5.376 to 9.603; -value: 0.001) × 10/μl; -0.417 (95%CI: -0.819 to -0.014; -value: 0.042) kg, -2.505 (95%CI: -3.835 to -1.175; -value: 0.001) mg/dl; and -1.93 (95%CI: -2.803 to -1.061; -value: 0.001) mg/dl change in platelet, weight, TC, and LDL-c for each SD increase in the score, respectively. A significant linear trend was observed in odds of hepatic fibrosis across the tertiles of the MedDiet score (P-trend: 0.008). This linear trend was attenuated but remained significant after the adjustment of the relevant confounders (P-trend: 0.032). Adherence to the MedDiet was independently associated with about 16% lower odds of having hepatic fibrosis in patients with NAFLD for each SD increase in the score.
Adherence to the MedDiet characterized by a high intake of whole grains, fruits, vegetables, legumes, nuts, and fish was associated with a lower risk of having hepatic fibrosis in patients with NAFLD. Further studies are required to elucidate the causal relationship of observed association in individuals of all ages, ethnicities, and etiologies of hepatic steatosis.
尽管有证据支持地中海饮食(MedDiet)对非酒精性脂肪性肝病(NAFLD)患者的肝脂肪变性有益,但MedDiet与肝纤维化的关系尚不清楚。本研究的目的是探讨伊朗NAFLD成年患者中的这种关联。
这项横断面研究纳入了来自拉万萨尔非传染性疾病(RaNCD)队列的3325名NAFLD患者。通过经过验证的食物频率问卷(FFQ)收集饮食摄入数据。MedDiet评分基于Trichopoulou等人构建的九点量表计算得出。使用脂肪肝指数(FLI)和纤维化-4(FIB-4)指数来预测人群中的肝脂肪变性和纤维化。应用多变量回归模型来确定关联。
MedDiet评分最高三分位数的受试者比最低三分位数的受试者具有更高的血小板计数以及更低的体重、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-c)和FLI(P值<0.05)。坚持MedDiet与血小板计数每增加一个标准差增加7.48(95%置信区间:5.376至9.603;P值:0.001)×10⁹/μl;体重降低0.417(95%置信区间:-0.819至-0.014;P值:0.042)kg;TC降低2.505(95%置信区间:-3.835至-1.175;P值:0.001)mg/dl;LDL-c降低1.93(95%置信区间:-2.803至-1.061;P值:0.001)mg/dl相关。在MedDiet评分的三分位数中,观察到肝纤维化的几率存在显著的线性趋势(P趋势:0.008)。在调整相关混杂因素后,这种线性趋势有所减弱但仍然显著(P趋势:0.032)。对于NAFLD患者,MedDiet评分每增加一个标准差,坚持MedDiet与肝纤维化几率降低约16%独立相关。
坚持以大量摄入全谷物、水果、蔬菜、豆类、坚果和鱼类为特征的MedDiet与NAFLD患者肝纤维化风险较低相关。需要进一步研究以阐明在所有年龄、种族和肝脂肪变性病因的个体中观察到的关联的因果关系。